← Leaderboards
Eugene Pietzak
Sloan-Kettering Inst Can Research
$1,516,847
Attributed
$1,516,847
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $514.2K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,516,847 · 1
By mechanism
R37$1,516,847 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- David B. Solit$21,393,031
- Hikmat Al-Ahmadie$4,559,862
- Raajit Rampal$5,822,249
- Ronglai Shen$3,190,387
- Mengmeng Du$2,352,665
Others in their field
Other Rising Stars on “Adjuvant Chemotherapy”
- Kathryn Marie Jones · Baylor College Of Medicine$3,103,804
- Amy Fowler · University Of Wisconsin-Madison$3,008,001
- Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research$2,617,533
- Nadine Norton · Mayo Clinic Jacksonville$2,431,858
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$2,101,095
- Nduka Mgbechinyere Amankulor · University Of Pennsylvania$2,082,285
Research focus
Adjuvant ChemotherapyAntibody-Drug ConjugatesBacillus Calmette-Guerin TherapyBcg LiveBiobankBladderBladder NeoplasmCancer CellCancer PatientCell Free DnaCell SeparationChemoresistanceChemotherapyCisplatinClinical ResearchClinical TrialsCohortCurative TreatmentsCystectomyCytotoxic ChemotherapyDependenceDiagnosisDisease ProgressionAcute
Grant awards (3)
Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer$514,185
R37 · FY2025 · CA · contact PI
Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer$488,477
R37 · FY2024 · CA · contact PI
Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer$514,185
R37 · FY2023 · CA · contact PI